| Recruitment status | Open public recruiting |
| Unique ID issued by UMIN | UMIN000033931 |
| Receipt No. | R000038697 |
| Official scientific title of the study | A study on colonic decompression as bridge to surgery for obstructive colon cancer. |
| Date of disclosure of the study information | 2018/09/01 |
| Last modified on | 2018/08/28 (Ver. 1) |
| Basic information | ||
| Official scientific title of the study | A study on colonic decompression as bridge to surgery for obstructive colon cancer. | |
| Title of the study (Brief title) | A study on colonic decompression as bridge to surgery for obstructive colon cancer. | |
| Region |
|
|
| Condition | |||
| Condition | obstructive colorectal cancer | ||
| Classification by specialty |
|
||
| Classification by malignancy | Malignancy | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | To verify the safety and long-term results of surgery (BTS: Bridge to Surgery) after decompression with colon stent for obstructive colon cancer. |
| Basic objectives2 | Safety |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | Complication rate during decompression and perioperative period. |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Historical |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Primary tumor resection within 3-30 days after stent(Nite-S colonic stent) placement. | |
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1)Colonic stricture presumed secondary to a carcinoma by preoperative imaging modalities such as abdominal and pelvic CT or colonoscope.
2)Patient with at least one of the following obstructive findings; 1. Intolerable for oral intake or necessary for fasting at the judgement of the attending physician 2. No fart 3. Bloating or abdominal pain 4. Abnormality of defecation such as constipation or frequent diarrhea 5. Nausea or vomiting 3)Written informed consent to participation in this trial |
|||
| Key exclusion criteria | 1)chemotherapy or radiotherapy before primary resection was performed
2)active overlapping cancer affecting the prognostic evaluation 3)Any other cases who are regarded as inadequate for study enrollment by investigators |
|||
| Target sample size | 40 | |||
| Research contact person | |
| Name of lead principal investigator | daisuke nakano |
| Organization | Tokyo Metropolitan Cancer and infectious diseases center Komagome Hospital |
| Division name | Surgery |
| Address | 504, 6-12-14, komagome, toshima-ku, Tokyo. |
| TEL | 09034294524 |
| gonchan5@cick.jp | |
| Public contact | |
| Name of contact person | daisuke nakano |
| Organization | Tokyo Metropolitan Cancer and infectious diseases center Komagome Hospital |
| Division name | Surgery |
| Address | 504, 6-12-14, komagome, toshima-ku, Tokyo. |
| TEL | 09034294524 |
| Homepage URL | |
| gonchan5@cick.jp | |
| Sponsor | |
| Institute | Tokyo Metropolitan Cancer and infectious diseases center Komagome Hospital |
| Institute | |
| Department | |
| Funding Source | |
| Organization | tokyo metropolitan government |
| Organization | |
| Division | |
| Category of Funding Organization | Local Government |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | がん・感染症センター都立駒込病院(東京都) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Open public recruiting | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000038697 |